A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. (Q25257862)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. |
scientific article |
Statements
1 reference
A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. (English)
1 reference
Pierre A Robe
1 reference
Didier Martin
1 reference
Adelin Albert
1 reference
Manuel Deprez
1 reference
Alain Chariot
1 reference
31 January 2006
1 reference
1 reference
1
0 references
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference